Inventor · disambiguated record
Martina Schäfer
Also filed as: SCHAEFER MARTINA · SCHAFER MARTINA · Schäfer Martina
30 granted patents·14 pending applications·246 citations·filing 2002–2023
97Inventor score
Top patents by PatentIndex Score
44 records- 0194US11130745B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2020·Granted Sep 28, 2021·4 cites·19 claims
- 0294US10300062B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2018·Granted May 28, 2019·11 cites·21 claims
- 0393US9949978B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·42 claims
- 0493US9949977B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·19 claims
- 0593US9481672B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2013·Granted Nov 1, 2016·18 cites·44 claims
- 0692US7235561B2Compound and a composition including such a compoundSCHERING AG·Filed 2002·Granted Jun 26, 2007·58 cites·58 claims
- 0790US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 0889US10815215B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2017·Granted Oct 27, 2020·5 cites·20 claims
- 0989US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 1089US7598260B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2007·Granted Oct 6, 2009·13 cites·79 claims
- 1188US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 1287US11713304B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2021·Granted Aug 1, 2023·1 cites·11 claims
- 1387US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 1486US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 1585US10221247B2Antibodies capable of binding to the coagulation factor XIa and uses thereofBayer Pharma AG·Filed 2017·Granted Mar 5, 2019·5 cites·12 claims
- 1685US9783614B2Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereofBayer Pharma AG·Filed 2013·Granted Oct 10, 2017·7 cites·6 claims
- 1784US10968216B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2017·Granted Apr 6, 2021·3 cites·16 claims
- 1884US9475809B2Substituted oxopyridine derivatives and use thereof as factor xia/plasmaBayer Pharma AG·Filed 2014·Granted Oct 25, 2016·6 cites·7 claims
- 1982US7291624B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Nov 6, 2007·16 cites·90 claims
- 2081US10138236B2Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivativesBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·15 claims
- 2179US9765070B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·4 cites·9 claims
- 2278US12486248B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2023·Granted Dec 2, 2025·0 cites·21 claims
- 2378US9918969B2Substituted oxopyridine derivatives and use thereof as factor XIa/plasmaBayer Pharma AG·Filed 2016·Granted Mar 20, 2018·2 cites·3 claims
- 2478US7504410B2Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Mar 17, 2009·13 cites·22 claims
- 2575US10722501B2Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereofBAYER AG·Filed 2017·Granted Jul 28, 2020·2 cites·19 claims
- 2674US10040866B2Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereofBayer Pharma AG·Filed 2017·Granted Aug 7, 2018·1 cites·12 claims
- 2774US9751843B2Substituted uracils and use thereofBayer Pharma AG·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 2867US11046783B2Antibodies capable of binding to the coagulation factor XIa and uses thereofBayer Pharma AG·Filed 2019·Granted Jun 29, 2021·0 cites·16 claims
- 2965US2020061063A1Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2019·Application pending·0 cites
- 3059US11787797B24,5-annulated 1,2,4-triazolonesBAYER AG·Filed 2021·Granted Oct 17, 2023·0 cites·2 claims
- 3154US2024174683A1Map4k1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 3248US2023072421A1Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancerBAYER AS·Filed 2020·Application pending·0 cites
- 3348US2009005373A1Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of sameHARTUNG INGO·Filed 2007·Application pending·0 cites
- 3445US2016222056A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3545US2016280688A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3645US2016237067A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3745US2016237045A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3845US2022144848A1Substituted oxopyridine derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 3945US2016244437A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4045US2016280699A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4145US2016237044A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4242US2016272617A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4342US2014050743A1Binding proteins to inhibitors of coagulation factorsDITTMER FRANK·Filed 2012·Application pending·0 cites
- 4438US11337973B2Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitorsBAYER AG·Filed 2018·Granted May 24, 2022·0 cites·31 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →